Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
RebrAIn
RebrAIn makes it possible for individuals with severe Parkinson's or essential tremor disorder to get DBS treatment with precision targeting. Neurosurgeons can more accurately pinpoint the target…
RebrAIn
RebrAIn makes it possible for individuals with severe Parkinson's or essential tremor disorder to get DBS treatment with precision targeting. Neurosurgeons can more accurately pinpoint the target…
TL;DR
Focus: AI-driven, patient-specific MRI targeting for Deep Brain Stimulation and radiosurgery (Parkinson's STN, Essential Tremor VIM)
Regulatory status: CE marked and FDA 510(k) cleared
Commercial footprint: Reported adoption across 60+ sites and 1,000+ targeting operations
Funding: Seed round closed Mar 18, 2024 (~€3.7M / $4,020,000 reported total funding)
Origins: Spin-off of University Hospital of Bordeaux and Inria
Company Overview
Problem Domain
Functional neurosurgery targeting for movement disorders (Deep Brain Stimulation and radiosurgery).
Industry
Medtech / Medical AI
Funding Track Record
€3.7 million
Round reported with participation from Nouvelle-Aquitaine Co-Investissement and existing/institutional backers; company About page displays investor logos including Karista and M-Capital.
Investor Signal
“Led by VC investor Karista with participation from regional institutional investor Nouvelle-Aquitaine Co-Investissement and other institutional/backer participation”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,500+
New This Week